CNTX
Context Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.51 / 10
Netural
Capital flow assessment is robust at 7.56/10, with positive trends across overall, block, Small, Large, and Extra-large flows, though Medium flow is negative. This indicates strong liquidity support. Analyst coverage is limited to one institution with a Strong Buy rating, but historical win rate is 100% (34.17% average return). Sentiment is neutral, and the analyst consensus is not overwhelming, yet the conviction is high.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-22
InstitutionJones Trading
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for CNTX?
- CNTX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.51/10 (Netural).
